Reform has unleashed Chinese drugs innovation boom, though some pharma firms may not survive under intense price pressure, industry leaders say | South China Morning Post
The number of domestically-developed new drugs approved for marketing has been creeping up each year, the conference heard. Photo: Shutterstock
The number of domestically-developed new drugs approved for marketing has been creeping up each year, the conference heard. Photo: Shutterstock